Skip to main content
DNA
NYSE Life Sciences

Ginkgo Posts Narrower Q3 Loss, Lands First Autonomous Lab Sale to Pharma Giant Novo

Tom Rudovsky · Reported by BusinessWire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$9.945
Mkt Cap
$670.709M
52W Low
$5.37
52W High
$18.22
52W Position info
85% above low
Off High info
45% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

DNA sits 85% above its 52-week low of $5.37.

Summary

Ginkgo reported Q3 2026 revenue of $28M, down 6% from $29M a year ago but up from $20M in Q2, and cut its GAAP net loss from continuing operations to $41M from $73M. Adjusted EBITDA improved to -$22M from -$53M, and cash burn was $27M for the quarter. The balance sheet showed $285M in cash, equivalents and marketable securities at September 30. The bigger story is commercial: Ginkgo signed its first autonomous lab sale to a top-tier pharma, Novo, at Novo's new Waltham, Massachusetts R&D site, and won an ARPA-H GIVE subcontract worth up to $17.5M to put its RAC and Catalyst systems into RNA-medicine manufacturing. Management reaffirmed full-year 2026 cash burn guidance of $125M-$150M. The company is pitching its Cloud Lab and autonomous lab equipment as an onshore alternative to overseas CROs, with 22 ADME customers signed in Q3, 20 of them first-time Ginkgo customers.

At the time of this announcement, DNA was trading at $9.95 on NYSE in the Life Sciences sector, with a market capitalization of approximately $670.7M. The 52-week trading range was $5.37 to $18.22. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

DNA - Latest Insights

DNA
Nov 09, 2026, 4:52 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $12.30
Real-time Price: $8.16 info
Change: -$4.14 (-34%) info
Market Cap: $531.565M info
DNA
Nov 05, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.80
Real-time Price: $8.16 info
Change: -$1.64 (-17%) info
Market Cap: $531.565M info
DNA
Aug 06, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $8.50
Real-time Price: $8.16 info
Change: -$0.340 (-4%) info
Market Cap: $531.565M info
DNA
May 07, 2026, 4:13 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.05
Real-time Price: $8.16 info
Change: -$0.890 (-10%) info
Market Cap: $531.565M info
DNA
May 07, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $8.56
Real-time Price: $8.16 info
Change: -$0.4044 (-5%) info
Market Cap: $531.565M info